CP and COVID-19: Convalescent plasma (CP) and immunoglobins (IG) collected from recovery COVID-19 patients contain neutralizing antibodies, which could bind to S1-RBD, inhibiting the binding of virus with receptor, thus limiting viral entry (Rojas et al., 2020).